Vienna, Austria, August 31 - September 4, 2008

The Symposium will focus on important new scientific and technological developments in the drug discovery process; particularly those relevant to medicinal chemistry. The meeting will create an environment for in-depth, informed discussions highlighting the importance of medicinal chemistry in the pharmaceutical industry, academia and drug research. It will also provide opportunities to re-emphasise the crucial position of medicinal chemistry in the drug discovery process and its pivotal role in linking and exploiting the associated biological sciences. Therefore, ISMC-2008 intends to create a forum for all scientists interested in medicinal chemistry and related fields.

Organised by: Austrian Chemical Society

Istanbul, Turkey, August 29 - September 2, 2006

The Symposium will focus on important new scientific and technological developments in the drug discovery process; particularly those relevant to medicinal chemistry. The meeting will create an environment for in-depth, informed discussions highlighting the importance of medicinal chemistry in the pharmaceutical industry, academia and drug research. It will also provide opportunities to re-emphasise the crucial position of medicinal chemistry in the drug discovery process and its pivotal role in linking and exploiting the associated biological sciences. Therefore, the ISMC-2006 intends to create a forum for all scientists interested in medicinal chemistry and related fields.

Organised by: Turkish Association of Pharmaceutical and Medicinal Chemistry

Copenhagen, Denmark & Malmoe, Sweden, August 15-19, 2004

The XVIIth ISMC will reflect that medicinal chemistry is a scientific discipline undergoing rapid development. The molecular biological revolution, new drug design technologies and the progressing mapping of the human genome have created a new exciting working field for scientists in these research areas. These developments are continuously broadening the borderlands between chemistry, informatics and biology and provide new opportunities for drug design on a rational basis. The ISMC 2004 will illustrate the integration of the complementary industrial and academic drug design  approaches.

Organised by: Danish Society for Pharmacology and Toxicology and Swedish Academy of Pharmaceutical Sciences

Barcelona, Spain, September 1-5, 2002

The Symposium will be especially focussed on the following topics:
- New methods and technologies in drug discovery
- Development of chemical libraries
- Early ADMET assessment
- Special topics in organic chemistry oriented to drug development

Organised by: Sociedad Española de Química Terapéutica

Bologna, Italy, September 18-22, 2000

Main topics inlcude:
- Antihypertensive Agents
- The Impact of Organic Chemistry on Drug Discovery
- Antiinfective Agents
- Hypolipidemics/Antiatherosclerotics
- Anticancer Agents

Organised by: Italian Chemical Society - Division of Medicinal Chemistry

Edinburgh, Scotland, September 1998

The scientific sessions will include 8 plenary lectures, and 52 invited lectures running in 3 parallel sessions, and  poster sessions.

The following themes will be included in the coverage
- New Technologies for Drug Discovery
- Ion Channels
- Intracellular Signalling
- Glycine Antagonists
- Predicting DMPK
- Growth Factors
- Glycochemistry and Glycobiology
- 7TM Receptors
- Protease Inhibition

Organised by: Biological and Medicinal Chemistry Sector of the Industrial Division

Maastricht, The Netherlands, September 8-12, 1996

Major topics are:
- Methodology and Design in Medicinal Chemistry
- The Genome as Target for Drug Design
- Enzymes and Enzyme-inhibitors
- CNS agents
- Antibacterial and Antifungal Drug Discovery

Organised by: La Société Royale de Chimie, Division Pharmacochemistry of the Royal Netherlands Chemical Society, Belgian Society for Pharmaceutical Sciences